Masimo - Home
30+ years of innovation and breakthrough advances have allowed Masimo, the makers of clinically proven SET® pulse oximetry, to miniaturize its monitoring technology and integrate it into a watch.
Masimo - Home
Masimo (NASDAQ: MASI) is a global medical technology company that develops and manufactures innovative noninvasive patient monitoring technologies, medical devices, and a wide array of sensors.
About - Masimo
Masimo is a global medical technology company that develops and manufactures innovative noninvasive patient monitoring technologies, medical devices, and a wide array of sensors.
About Masimo
Masimo is known for its exceptional accuracy and reliability during challenging conditions, and it now brings its expertise to consumers looking to take control of their personal health, make better health decisions, and monitor their overall physiological status.
Masimo - Monitoring Solutions
Masimo offers multiple advanced noninvasive and continuous monitoring technologies, available on a single integrated platform and on select third-party multi-parameter monitors. Masimo's breakthrough Signal Extraction Technology ® (SET ® ) overcomes the limitations of conventional pulse oximetry with the ability to measure through motion and ...
Shop All | Masimo Health Products
Discover all Masimo Consumer Health products, including W1 Health Watch, Stork, MightSat, RadiusT, and Opioid Halo
Masimo: Health At Home
Decades of innovation and breakthrough advances have allowed Masimo, the makers of clinically proven SET® pulse oximetry, to miniaturize a monitoring technology based on SET® and integrate it into a watch.
Masimo - Contact
Masimo Contact Us - We welcome your feedback! If you have a question, comment or concern, please complete the form below and we will respond within 2 business days. Skip to content
Masimo - PRESS RELEASE
Jan 9, 2025 · Masimo (NASDAQ: MASI), a leading developer of medical technology solutions and consumer health and audio devices, is expanding its premium Denon brand to introduce its latest innovation, Masimo AAT™ (Adaptive Acoustic Technology™).
Masimo Announces Select Preliminary 2024 Financial Results and …
Jan 17, 2025 · Masimo SET ® has also been shown to help clinicians reduce severe retinopathy of prematurity in neonates, improve CCHD screening in newborns, and, when used for continuous monitoring with Masimo Patient SafetyNet ™ in post-surgical wards, reduce rapid response